Diagnostic News and Research

RSS
Manhattan acquires Senior Scientific

Manhattan acquires Senior Scientific

ITI receives FDA clearance for new Q fever assay kit

ITI receives FDA clearance for new Q fever assay kit

DiagnoCure reports net loss of $1,601,439 for second quarter 2011

DiagnoCure reports net loss of $1,601,439 for second quarter 2011

PREMIER Biosoft, Waters partner to advance lipidomics research

PREMIER Biosoft, Waters partner to advance lipidomics research

Brainlab enters into definitive agreement to acquire Voyant Health

Brainlab enters into definitive agreement to acquire Voyant Health

Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year

Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year

Life Technologies develops qPCR-based accurate test to detect E. coli

Life Technologies develops qPCR-based accurate test to detect E. coli

Merge Healthcare, Ophthalmic Imaging Systems enter definitive merger agreement

Merge Healthcare, Ophthalmic Imaging Systems enter definitive merger agreement

EUS-guided GI biopsies with Cook Medical's new, large-core biopsy needle overcomes limitations

EUS-guided GI biopsies with Cook Medical's new, large-core biopsy needle overcomes limitations

Medizintechnik acquires BSD-2000/3D/MR integrated hyperthermia system

Medizintechnik acquires BSD-2000/3D/MR integrated hyperthermia system

Ohio's Adena Health System chooses eClinicalWorks EHR solution for physicians

Ohio's Adena Health System chooses eClinicalWorks EHR solution for physicians

New UH Seidman Cancer Center center to offer latest treatments and technology

New UH Seidman Cancer Center center to offer latest treatments and technology

Women with breast cancer do not benefit from flaxseed

Women with breast cancer do not benefit from flaxseed

Women with ovarian cancer do not benefit from CA-125 and transvaginal ultrasound

Women with ovarian cancer do not benefit from CA-125 and transvaginal ultrasound

ImaginAb, GE Healthcare sign master research deal to develop new PET diagnostic imaging agents

ImaginAb, GE Healthcare sign master research deal to develop new PET diagnostic imaging agents

Positive results from Plexxikon's vemurafenib Phase 2 and 3 trial against metastatic melanoma

Positive results from Plexxikon's vemurafenib Phase 2 and 3 trial against metastatic melanoma

Additional data supporting utility of PAM50 gene signature for breast cancer to be presented at ASCO 2011

Additional data supporting utility of PAM50 gene signature for breast cancer to be presented at ASCO 2011

Response Genetics' clinical approaches to improve cancer care to be presented at ASCO 2011

Response Genetics' clinical approaches to improve cancer care to be presented at ASCO 2011

Battelle, Perma-Fix sign exclusive option agreement to make medical isotopes

Battelle, Perma-Fix sign exclusive option agreement to make medical isotopes

Nuvera announces results of blinded study on breast cancer assay for taxane chemotherapy response

Nuvera announces results of blinded study on breast cancer assay for taxane chemotherapy response

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.